Sodium in PDB 8y6f: The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin
Protein crystallography data
The structure of The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin, PDB code: 8y6f
was solved by
C.Yuan,
M.Huang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
23.52 /
2.01
|
Space group
|
P 42 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
219.66,
219.66,
148.31,
90,
90,
90
|
R / Rfree (%)
|
24.5 /
28.7
|
Other elements in 8y6f:
The structure of The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin
(pdb code 8y6f). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 4 binding sites of Sodium where determined in the
The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin, PDB code: 8y6f:
Jump to Sodium binding site number:
1;
2;
3;
4;
Sodium binding site 1 out
of 4 in 8y6f
Go back to
Sodium Binding Sites List in 8y6f
Sodium binding site 1 out
of 4 in the The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Na201
b:12.1
occ:1.00
|
OE1
|
C:GLU135
|
2.2
|
17.2
|
1.0
|
OE1
|
I:GLU135
|
2.5
|
18.3
|
1.0
|
OD1
|
I:ASP132
|
2.5
|
18.4
|
1.0
|
OD1
|
C:ASP132
|
2.6
|
23.6
|
1.0
|
FE
|
I:FE201
|
3.0
|
65.5
|
1.0
|
CD
|
C:GLU135
|
3.4
|
18.9
|
1.0
|
CG
|
I:ASP132
|
3.6
|
21.4
|
1.0
|
CD
|
I:GLU135
|
3.7
|
19.5
|
1.0
|
CG
|
C:ASP132
|
3.7
|
21.4
|
1.0
|
O
|
C:HOH444
|
4.0
|
27.4
|
1.0
|
OE2
|
C:GLU135
|
4.0
|
20.0
|
1.0
|
CB
|
I:ASP132
|
4.3
|
15.2
|
1.0
|
OE2
|
I:GLU135
|
4.4
|
19.7
|
1.0
|
CB
|
C:ASP132
|
4.4
|
18.0
|
1.0
|
CB
|
C:GLU135
|
4.5
|
19.0
|
1.0
|
CG
|
C:GLU135
|
4.5
|
16.8
|
1.0
|
OD2
|
I:ASP132
|
4.6
|
18.9
|
1.0
|
OD2
|
C:ASP132
|
4.7
|
17.7
|
1.0
|
CA
|
I:ASP132
|
4.7
|
17.5
|
1.0
|
CB
|
I:GLU135
|
4.7
|
20.1
|
1.0
|
CA
|
C:ASP132
|
4.8
|
17.2
|
1.0
|
CG
|
I:GLU135
|
4.8
|
14.2
|
1.0
|
|
Sodium binding site 2 out
of 4 in 8y6f
Go back to
Sodium Binding Sites List in 8y6f
Sodium binding site 2 out
of 4 in the The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Na201
b:21.9
occ:1.00
|
O
|
D:HOH307
|
2.1
|
28.9
|
1.0
|
O
|
D:HOH423
|
2.2
|
27.4
|
1.0
|
OE2
|
D:GLU63
|
2.7
|
27.5
|
1.0
|
OE1
|
D:GLU108
|
3.1
|
20.6
|
1.0
|
OE1
|
D:GLN59
|
3.3
|
31.8
|
1.0
|
CD
|
D:GLU108
|
3.5
|
18.4
|
1.0
|
OE2
|
D:GLU108
|
3.7
|
21.2
|
1.0
|
O
|
D:HOH304
|
3.9
|
22.5
|
1.0
|
CD
|
D:GLU63
|
3.9
|
19.9
|
1.0
|
O
|
D:HOH401
|
4.1
|
25.6
|
1.0
|
CB
|
D:ALA145
|
4.2
|
15.6
|
1.0
|
OH
|
D:TYR35
|
4.2
|
17.5
|
1.0
|
CD
|
D:GLN59
|
4.3
|
23.2
|
1.0
|
CE2
|
D:TYR35
|
4.3
|
15.4
|
1.0
|
CG
|
D:GLU63
|
4.6
|
16.7
|
1.0
|
CG
|
D:GLU108
|
4.6
|
20.5
|
1.0
|
CZ
|
D:TYR35
|
4.6
|
16.7
|
1.0
|
CE1
|
D:HIS66
|
4.7
|
26.0
|
1.0
|
OE1
|
D:GLU63
|
4.9
|
25.3
|
1.0
|
CB
|
D:GLN59
|
4.9
|
19.1
|
1.0
|
|
Sodium binding site 3 out
of 4 in 8y6f
Go back to
Sodium Binding Sites List in 8y6f
Sodium binding site 3 out
of 4 in the The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Na201
b:22.0
occ:1.00
|
NE2
|
F:HIS181
|
2.8
|
21.0
|
1.0
|
NE2
|
J:HIS181
|
2.9
|
22.2
|
1.0
|
NE2
|
G:HIS181
|
3.0
|
20.9
|
1.0
|
NE2
|
K:HIS181
|
3.1
|
21.4
|
1.0
|
CD2
|
J:LEU177
|
3.4
|
17.0
|
1.0
|
CD2
|
F:HIS181
|
3.7
|
17.6
|
1.0
|
CE1
|
F:HIS181
|
3.7
|
20.8
|
1.0
|
CD2
|
K:LEU177
|
3.8
|
15.4
|
1.0
|
CD2
|
F:LEU177
|
3.8
|
17.0
|
1.0
|
CE1
|
J:HIS181
|
3.8
|
24.0
|
1.0
|
CD2
|
J:HIS181
|
3.9
|
21.3
|
1.0
|
CE1
|
G:HIS181
|
3.9
|
22.8
|
1.0
|
CE1
|
K:HIS181
|
3.9
|
22.1
|
1.0
|
CD2
|
K:HIS181
|
3.9
|
23.7
|
1.0
|
CD2
|
G:HIS181
|
4.0
|
23.0
|
1.0
|
CD2
|
G:LEU177
|
4.0
|
18.9
|
1.0
|
ND1
|
F:HIS181
|
4.8
|
19.2
|
1.0
|
CG
|
F:HIS181
|
4.8
|
20.4
|
1.0
|
CG
|
J:LEU177
|
4.9
|
15.9
|
1.0
|
ND1
|
J:HIS181
|
4.9
|
23.1
|
1.0
|
CG
|
J:HIS181
|
5.0
|
19.6
|
1.0
|
|
Sodium binding site 4 out
of 4 in 8y6f
Go back to
Sodium Binding Sites List in 8y6f
Sodium binding site 4 out
of 4 in the The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 4 of The Crystal Structure of Mmps Cleavable Human Heavy Chain Ferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na202
b:23.7
occ:1.00
|
O
|
L:HOH320
|
2.2
|
32.6
|
1.0
|
O
|
L:HOH394
|
2.4
|
29.5
|
1.0
|
OE2
|
L:GLU63
|
2.5
|
23.6
|
1.0
|
OE2
|
L:GLU108
|
2.5
|
22.6
|
1.0
|
O
|
L:HOH310
|
3.0
|
24.2
|
1.0
|
CD
|
L:GLU108
|
3.2
|
22.4
|
1.0
|
OE1
|
L:GLU108
|
3.2
|
24.3
|
1.0
|
CD
|
L:GLU63
|
3.7
|
23.3
|
1.0
|
OE1
|
L:GLN59
|
4.0
|
29.4
|
1.0
|
CB
|
L:ALA145
|
4.1
|
14.7
|
1.0
|
CE1
|
L:HIS66
|
4.3
|
26.5
|
1.0
|
OH
|
L:TYR35
|
4.4
|
18.2
|
1.0
|
O
|
L:HOH448
|
4.5
|
31.0
|
1.0
|
CE2
|
L:TYR35
|
4.5
|
14.9
|
1.0
|
CG
|
L:GLU108
|
4.6
|
16.1
|
1.0
|
CG
|
L:GLU63
|
4.6
|
18.0
|
1.0
|
OE1
|
L:GLU63
|
4.6
|
19.2
|
1.0
|
OE1
|
L:GLN142
|
4.7
|
22.6
|
1.0
|
CZ
|
L:TYR35
|
4.9
|
18.1
|
1.0
|
FE
|
L:FE203
|
4.9
|
31.7
|
1.0
|
ND1
|
L:HIS66
|
5.0
|
23.9
|
1.0
|
|
Reference:
W.Yan,
H.Li,
J.Ning,
S.Huang,
L.Jiang,
P.Xu,
M.Huang,
C.Yuan.
Engineered Protein Cages with Enhanced Extracellular Drug Release For Elevated Antitumor Efficacy. Int.J.Biol.Macromol. V. 267 31492 2024.
ISSN: ISSN 0141-8130
PubMed: 38604418
DOI: 10.1016/J.IJBIOMAC.2024.131492
Page generated: Wed Oct 9 14:24:09 2024
|